These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26590147)

  • 1. Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infection.
    Henao-Tamayo MI; Obregón-Henao A; Arnett K; Shanley CA; Podell B; Orme IM; Ordway DJ
    J Leukoc Biol; 2016 Apr; 99(4):605-17. PubMed ID: 26590147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid rebound of the Treg compartment in DEREG mice limits the impact of Treg depletion on mycobacterial burden, but prevents autoimmunity.
    Berod L; Stüve P; Varela F; Behrends J; Swallow M; Kruse F; Krull F; Ghorbani P; Mayer CT; Hölscher C; Sparwasser T
    PLoS One; 2014; 9(7):e102804. PubMed ID: 25050936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells.
    Ordway DJ; Shang S; Henao-Tamayo M; Obregon-Henao A; Nold L; Caraway M; Shanley CA; Basaraba RJ; Duncan CG; Orme IM
    Clin Vaccine Immunol; 2011 Sep; 18(9):1527-35. PubMed ID: 21795460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.
    Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH
    mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load.
    Quinn KM; McHugh RS; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Immunol Cell Biol; 2006 Oct; 84(5):467-74. PubMed ID: 16869940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination.
    Kang H; Yuan Q; Ma H; Hu ZD; Han DP; Wu K; Lowrie DB; Fan XY
    Immunology; 2014 Dec; 143(4):661-9. PubMed ID: 24965530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-
    Rivas-Santiago CE; Guerrero GG
    Biomed Res Int; 2017; 2017():8796760. PubMed ID: 29090221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
    Luo Y; Jiang W; Da Z; Wang B; Hu L; Zhang Y; An R; Yu H; Sun H; Tang K; Tang Z; Wang Y; Jing T; Zhu B
    Scand J Immunol; 2012 Mar; 75(3):293-300. PubMed ID: 22117839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of T regulatory cell depletion and donor BCG vaccination on Mycobacterium tuberculosis H37Ra infection using an in vitro model of human PBMC infection.
    Bhavanam S; Rayat GR; Keelan M; Kunimoto D; Drews SJ
    Pathog Dis; 2020 Dec; 78(9):. PubMed ID: 33300047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with
    Aagaard C; Knudsen NPH; Sohn I; Izzo AA; Kim H; Kristiansen EH; Lindenstrøm T; Agger EM; Rasmussen M; Shin SJ; Rosenkrands I; Andersen P; Mortensen R
    J Immunol; 2020 Oct; 205(8):2146-2155. PubMed ID: 32887748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis.
    Dhiman R; Periasamy S; Barnes PF; Jaiswal AG; Paidipally P; Barnes AB; Tvinnereim A; Vankayalapati R
    J Immunol; 2012 Jul; 189(2):897-905. PubMed ID: 22711885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.
    Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ
    Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.
    Komine-Aizawa S; Yamazaki T; Yamazaki T; Hattori S; Miyamoto Y; Yamamoto N; Haga S; Sugitani M; Honda M; Hayakawa S; Yamamoto S
    Clin Vaccine Immunol; 2010 Oct; 17(10):1500-6. PubMed ID: 20685935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-15 as an immune adjuvant to increase the efficacy of Mycobacterium bovis bacillus Calmette-Guérin vaccination.
    Umemura M; Nishimura H; Saito K; Yajima T; Matsuzaki G; Mizuno S; Sugawara I; Yoshikai Y
    Infect Immun; 2003 Oct; 71(10):6045-8. PubMed ID: 14500526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.
    Xu Y; Yang E; Wang J; Li R; Li G; Liu G; Song N; Huang Q; Kong C; Wang H
    Immunology; 2014 Oct; 143(2):277-86. PubMed ID: 24773322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.